Hongnan Cao

1.1k citations
26 papers · 824 indexed · h-index 15
Topics
Porphyrin Metabolism and Disorders (9 papers)Enzyme Structure and Function (6 papers)Biochemical and Molecular Research (5 papers)

In The Last Decade

Hongnan Cao

25 papers receiving 813 citations

Peers

Hongnan Cao
Comparison fields: 5 of 100
  • Molecular Biology 446
  • Nephrology 171
  • Pharmacology 117
  • Organic Chemistry 104
  • Biomedical Engineering 97
Replace Hanki Lee with:
Hanki Lee South Korea
Takashi Sano Japan
Haonan Wang China
Davide Garella Italy
Shogo Nakano Japan
Hai‐Liang Zhu China
Xiangdong Hu China
Stéphane Chambert France
Sining Li China
Ban‐Feng Ruan China
Hongnan Cao relative to Hanki Lee South Korea Hanki Lee's profile →
Citations per field
00.5×10.1×
Hanki Lee · 1×
Citations per year

Countries citing papers authored by Hongnan Cao

Since Specialization
Citations

This map shows the geographic impact of Hongnan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongnan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongnan Cao more than expected).

Fields of papers citing papers by Hongnan Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongnan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongnan Cao. The network helps show where Hongnan Cao may publish in the future.

Co-authorship network of co-authors of Hongnan Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Hongnan Cao. A scholar is included among the top collaborators of Hongnan Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongnan Cao. Hongnan Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 21
2 11
3 29
4 3
5 23
6 60
7 19
8 52
9 4
10 5
11 13
12 35
13 5
14 27
15
Crystallographic, Kinetic and Computational Studies on the Reaction Mechanism of Xanthine Oxidoreductase
0
16 11
17 24
18 110
19 89
20 50

About Hongnan Cao

Hongnan Cao is a scholar working on Nephrology, Biotechnology and Molecular Biology, having authored 26 papers that have together received 824 indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (9 papers), Enzyme Structure and Function (6 papers) and Biochemical and Molecular Research (5 papers). The work is most often cited by research in Nephrology (171 citations), Pharmacology (79 citations) and Biochemistry (42 citations). Hongnan Cao has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Russ Hille, James M. Pauff, Jeffrey Skolnick, G.N. Phillips, Paul F. Nealey, Hongyi Zhou, Kenji Yoshimoto, Mark P. Stoykovich, James E. Hall and Leonidas E. Ocola. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026